Central Nervous System Toxicity Attributable to Epidural Ropivacaine Hydrochloride
Open Access
- 1 April 1998
- journal article
- case report
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 26 (2) , 204-206
- https://doi.org/10.1177/0310057x9802600214
Abstract
Ropivacaine, a new local anaesthetic agent, has been demonstrated to have less potential than bupivacaine for central nervous system toxicity on the basis of human and animal studies. We report a case of a convulsion secondary to presumed inadvertent intravascular injection of 20 mg of ropivacaine in a 44 kg patient during an epidural for chronic pain. There were minimal signs of cardiovascular toxicity.Keywords
This publication has 9 references indexed in Scilit:
- Continuous extradural infusion of ropivacaine for prevention of postoperative pain after major orthopaedic surgeryBritish Journal of Anaesthesia, 1996
- Treatment of Acute Systemic Toxicity After the Rapid Intravenous Injection of Ropivacaine and Bupivacaine in the Conscious DogAnesthesia & Analgesia, 1991
- A Comparison of Ropivacaine 0.5% and Bupivacaine 0.5% for Brachial Plexus BlockAnesthesiology, 1991
- Comparative Systemic Toxicity of Convulsant and Supraconvulsant Doses of Intravenous Ropivacaine, Bupivacaine, and Lidocaine in the Conscious DogAnesthesia & Analgesia, 1989
- Disposition Kinetics of Ropivacaine in HumansAnesthesia & Analgesia, 1989
- Acute Toxicity of Ropivacaine Compared with That of BupivacaineAnesthesia & Analgesia, 1989
- Myocardial and Cerebral Drug Concentrations and the Mechanisms of Death after Fatal Intravenous Doses of Lidocaine, Bupivacaine, and Ropivacaine in the SheepAnesthesia & Analgesia, 1989